Elevoplasty Featured on CBS New York Channel 2 with Healthcare News Anchor Dr. Max Gomez Reporting
View Video Clip
Read More
Zelegent Acquires MISH Technology Platform, Extending Product Pipeline into Obstructive Sleep Apnea Therapeutics
While Elevoplasty® Grows in Recognition and Popularity with Physicians, MISH Platform Allows for Development of 2nd Product with Same Sales Call Point LA JOLLA, CA – September 15, ...
Read More
Cook Medical and Zelegent, Inc. begin sales and marketing agreement
Bloomington, Ind. and La Jolla, Calif. – January 8th, 2019 – Today, Cook Medical and Zelegent, Inc. announce an agreement to enhance treatment options for patients suffering from ...
Read More
Zelegent, Inc. Elevoplasty® Procedure Receives U.S. Patent
First issued patent of a portfolio of applications covering the new minimally-invasive procedure to treat snoring. IRVINE, CA –June 21st, 2018 – Zelegent, Inc., a medical technology company ...
Read More
Zelegent, Inc. Launches Multi-Center Snoring Reduction Trial
Zelegent, Inc., a clinical-stage medical technology company developing innovative tools for otolaryngologist sleep specialists, today announced the beginning of enrollment in its multi-center pivotal snoring reduction trial, the S.I.LE.N.C.E. study.
Read More
Zelegent, Inc. Pilot Study Results Show Significant Improvement in All Study Endpoints
Zelegent, Inc. presented clinical outcomes from its pilot clinical study today at the 3rd Congress of European Otorhinolaryngology and Head and Neck Surgery (ORL-HNS) in Prague, Czech Republic.
Read More
Zelegent Appoints Clinical Advisory Board, Joins Incubator & Will Unveil Study Results Next Week
Zelegent, Inc. announced today that five experts in sleep disorder therapy have joined its clinical advisory board, the company has joined the EvoNexus incubator program, and the company plans to present results from its first clinical trial next week.
Read More
Snorx, Inc. Changes Name to Zelegent, Inc.
Snorx, Inc. today reported that the Company’s Board of Directors has voted to change the name of the Company to Zelegent, Inc.
Read More
Snorx, Inc. Taps Medical Technology Industry Veteran Alexander K. Arrow, MD as Chief Executive Officer
Snorx, Inc. today reported that Alexander K. Arrow, M.D. has been appointed Chief Executive Officer and will be leading the company as it enters its regulatory submission phase and prepares to manufacture its first product.
Read More